279 related articles for article (PubMed ID: 11410486)
1. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications.
Tabor MP; Brakenhoff RH; van Houten VM; Kummer JA; Snel MH; Snijders PJ; Snow GB; Leemans CR; Braakhuis BJ
Clin Cancer Res; 2001 Jun; 7(6):1523-32. PubMed ID: 11410486
[TBL] [Abstract][Full Text] [Related]
2. Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study.
Tabor MP; Brakenhoff RH; Ruijter-Schippers HJ; Kummer JA; Leemans CR; Braakhuis BJ
Clin Cancer Res; 2004 Jun; 10(11):3607-13. PubMed ID: 15173066
[TBL] [Abstract][Full Text] [Related]
3. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications.
Braakhuis BJ; Tabor MP; Kummer JA; Leemans CR; Brakenhoff RH
Cancer Res; 2003 Apr; 63(8):1727-30. PubMed ID: 12702551
[TBL] [Abstract][Full Text] [Related]
4. Does loss of heterozygosity in critical genome regions predict a local relapse in patients after laryngectomy?
Szukała K; Sowińska A; Wierzbicka M; Biczysko W; Szyfter W; Szyfter K
Mutat Res; 2006 Aug; 600(1-2):67-76. PubMed ID: 16814812
[TBL] [Abstract][Full Text] [Related]
5. Genetic progression and clonal relationship of recurrent premalignant head and neck lesions.
Califano J; Westra WH; Meininger G; Corio R; Koch WM; Sidransky D
Clin Cancer Res; 2000 Feb; 6(2):347-52. PubMed ID: 10690509
[TBL] [Abstract][Full Text] [Related]
6. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer.
van Houten VM; Tabor MP; van den Brekel MW; Kummer JA; Denkers F; Dijkstra J; Leemans R; van der Waal I; Snow GB; Brakenhoff RH
J Pathol; 2002 Dec; 198(4):476-86. PubMed ID: 12434417
[TBL] [Abstract][Full Text] [Related]
7. Second esophageal tumors in patients with head and neck squamous cell carcinoma: an assessment of clonal relationships.
Califano J; Leong PL; Koch WM; Eisenberger CF; Sidransky D; Westra WH
Clin Cancer Res; 1999 Jul; 5(7):1862-7. PubMed ID: 10430093
[TBL] [Abstract][Full Text] [Related]
8. Genetic alterations between primary head and neck squamous cell carcinoma and recurrence after radiotherapy: recurrence, genetically related cancer, or second primary?
Deganello A; Franchi A; Sardi I; Pignataro L; Leemans CR; Gallo O
Cancer; 2010 Mar; 116(5):1291-7. PubMed ID: 20087960
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of head and neck tumors by analysis of telomerase activity and a panel of microsatellite markers.
Fiedler W; Hoppe C; Schimmel B; Koscielny S; Dahse R; Bereczki Z; Claussen U; Ernst G; von Eggeling F
Int J Mol Med; 2002 Apr; 9(4):417-23. PubMed ID: 11891539
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
Nathan CO; Amirghahri N; Rice C; Abreo FW; Shi R; Stucker FJ
Laryngoscope; 2002 Dec; 112(12):2129-40. PubMed ID: 12461330
[TBL] [Abstract][Full Text] [Related]
11. Allelotype of head and neck squamous cell carcinoma.
Nawroz H; van der Riet P; Hruban RH; Koch W; Ruppert JM; Sidransky D
Cancer Res; 1994 Mar; 54(5):1152-5. PubMed ID: 8118797
[TBL] [Abstract][Full Text] [Related]
12. Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis.
Spafford MF; Koch WM; Reed AL; Califano JA; Xu LH; Eisenberger CF; Yip L; Leong PL; Wu L; Liu SX; Jerónimo C; Westra WH; Sidransky D
Clin Cancer Res; 2001 Mar; 7(3):607-12. PubMed ID: 11297256
[TBL] [Abstract][Full Text] [Related]
13. Allelic losses in OraTest-directed biopsies of patients with prior upper aerodigestive tract malignancy.
Guo Z; Yamaguchi K; Sanchez-Cespedes M; Westra WH; Koch WM; Sidransky D
Clin Cancer Res; 2001 Jul; 7(7):1963-8. PubMed ID: 11448911
[TBL] [Abstract][Full Text] [Related]
14. An allelotype of squamous carcinoma of the head and neck using microsatellite markers.
Ah-See KW; Cooke TG; Pickford IR; Soutar D; Balmain A
Cancer Res; 1994 Apr; 54(7):1617-21. PubMed ID: 8137268
[TBL] [Abstract][Full Text] [Related]
15. Genetic discordance between primary tumours and metastases of head and neck cancer detected by microsatellite analysis.
Götte K; Riedel F; Schäfer C; Coy JF; Hörmann K
Oncol Rep; 2002; 9(4):829-34. PubMed ID: 12066217
[TBL] [Abstract][Full Text] [Related]
16. Tetranucleotide microsatellite instability in surgical margins for prediction of local recurrence of head and neck squamous cell carcinoma.
Temam S; Casiraghi O; Lahaye JB; Bosq J; Zhou X; Julieron M; Mamelle G; Lee JJ; Mao L; Luboinski B; Benard J; Janot F
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4022-8. PubMed ID: 15217934
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of p53 in tumor-distant epithelia of head and neck cancer patients is associated with an increased incidence of second primary carcinoma.
Homann N; Nees M; Conradt C; Dietz A; Weidauer H; Maier H; Bosch FX
Clin Cancer Res; 2001 Feb; 7(2):290-6. PubMed ID: 11234882
[TBL] [Abstract][Full Text] [Related]
18. Molecular support for field cancerization in the head and neck.
Lydiatt WM; Anderson PE; Bazzana T; Casale M; Hughes CJ; Huvos AG; Lydiatt DD; Schantz SP
Cancer; 1998 Apr; 82(7):1376-80. PubMed ID: 9529031
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity at 9p and p53 immunopositivity in surgical margins predict local relapse in head and neck squamous cell carcinoma.
Graveland AP; Golusinski PJ; Buijze M; Douma R; Sons N; Kuik DJ; Bloemena E; Leemans CR; Brakenhoff RH; Braakhuis BJ
Int J Cancer; 2011 Apr; 128(8):1852-9. PubMed ID: 20568113
[TBL] [Abstract][Full Text] [Related]
20. P53 expression and polysomies of chromosome 9, 17 in head and neck cancer prognosis.
Charuruks N; Shin DM; Voravud N; Ro JY; Hong WK; Hittelman WN
J Med Assoc Thai; 1999 May; 82(5):466-76. PubMed ID: 10443096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
